[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100637676":3},{"organization":4,"armGroups":7,"interventions":17,"overallOfficials":10,"centralContacts":28,"locations":34,"responsibleParty":51,"collaborators":10,"id":55,"slug":56,"hasResults":57,"nctId":58,"briefTitle":59,"officialTitle":59,"acronym":10,"eligibilityCriteria":60,"healthyVolunteers":57,"sex":61,"minAge":62,"maxAge":10,"enrollmentInfo":63,"targetDuration":66,"studyType":67,"phases":10,"briefSummary":68,"conditions":69,"keywords":10,"overallStatus":37,"whyStopped":10,"lastUpdateSubmitDate":71,"lastUpdatePostDateStruct":72,"startDateStruct":75,"completionDateStruct":77,"leadSponsor":79,"locationsCount":80},{"fullName":5,"class":6},"Tongji Hospital","OTHER",[8,13],{"label":9,"type":10,"description":10,"interventionNames":11},"Liver resection group",null,[12],"Procedure: liver resection",{"label":14,"type":10,"description":10,"interventionNames":15},"Non-surgery group",[16],"Drug: Systemic therapy combined with locoregional interventions",[18,23],{"type":19,"name":20,"description":21,"armGroupLabels":22,"otherNames":10},"PROCEDURE","liver resection","Patients undergo liver resection for tumor.",[9],{"type":24,"name":25,"description":26,"armGroupLabels":27,"otherNames":10},"DRUG","Systemic therapy combined with locoregional interventions","Patients recieve PD-1 inhibitors combined with targeted drugs and locoregional interventions",[14],[29],{"name":30,"role":31,"phone":32,"phoneExt":10,"email":33},"Qi Cheng, M.D.","CONTACT","13871459541","chengqi@hust.edu.cn",[35],{"facility":36,"status":37,"city":38,"state":39,"zip":40,"country":41,"countryCode":42,"cosmosGeoPoint":43,"geoPoint":48,"contacts":49},"Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology","RECRUITING","Wuhan","Hubei","430030","China","CN",{"type":44,"coordinates":45},"Point",[46,47],114.26667,30.58333,{"lat":47,"lon":46},[50],{"name":30,"role":31,"phone":32,"phoneExt":10,"email":33},{"type":52,"investigatorFullName":53,"investigatorTitle":54,"investigatorAffiliation":5,"oldNameTitle":10,"oldOrganization":10},"PRINCIPAL_INVESTIGATOR","Cheng Qi","Deputy Director of Hepatobiliary and Pancreatic Surgery Department","100637676","prospective-clinical-database-construction-for-liver-cancer-diagnosis-and-treatment-100637676",false,"NCT07587216","Prospective Clinical Database Construction for Liver Cancer Diagnosis and Treatment","Inclusion Criteria:\n\n* Male or female aged ≥18 years at the time of signing the informed consent form\n* Clinically or histologically confirmed diagnosis of liver cancer\n* Recieving treatment and follow-up in Tongji Hospital\n\nExclusion Criteria:\n\n\\- Refuse participanting in this study","ALL","18 Years",{"count":64,"type":65},800,"ESTIMATED","2 Years","OBSERVATIONAL","This study is a prospective, observational, real-world cohort study. We aim to establish a prospective database in the Department of Hepatobiliary and Pancreatic Surgery, systematically collecting and integrating patients' full-course diagnostic and therapeutic information along with long-term outcomes. This will enable objective evaluation of prognosis and treatment efficacy in real-world clinical practice, while providing a data foundation and evidence support for subsequent optimization of clinical decision-makin",[70],"Liver Cancer (Primary and Metastatic)","2026-06-02",{"date":73,"type":74},"2026-06-04","ACTUAL",{"date":76,"type":74},"2026-01-01",{"date":78,"type":65},"2029-12-31",{"name":5,"class":6},1]